Myelofibrosis (MF) - Market Insight, Epidemiology And Market Forecast - 2032

Published	Pages	Publisher	Report code
Sep 2022	225	DelveInsight	ASDR-609114

Published: Sep 2022 - Pages : 225 - Publisher : DelveInsight - Report code : ASDR-609114

Geron Corporation
AbbVie
Sierra Oncology
Galecto Biotech
Actuate Therapeutics
Kartos Therapeutics
Menarini Group
Telios Pharma
Novartis Pharmaceuticals
NS Pharma
Karyopharm Therapeutics
Incyte Corporation
Incyte
Celgene/Bristol Myers Squibb
MorphoSys
Imago BioSciences
Roche

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

Published: June, 2022 | Report code: ASDR-607637